Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

被引:0
|
作者
Ruiwen Ruan
Li Li
Xuan Li
Chunye Huang
Zhanmin Zhang
Hongguang Zhong
Shaocheng Zeng
Qianqian Shi
Yang Xia
Qinru Zeng
Qin Wen
Jingyi Chen
Xiaofeng Dai
Jianping Xiong
Xiaojun Xiang
Wan Lei
Jun Deng
机构
[1] First Affiliated Hospital of Nanchang University,Department of Oncology
[2] Jiangxi Key Laboratory for lndividualized Cancer Therapy,undefined
来源
关键词
Fibroblast growth factor receptor; Immune checkpoint blockade; Tumor microenvironment; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Therapeutic potential of MET inhibitor combined with immune checkpoint blockade in pancreatic cancer
    Gao, Mei
    Lin, Miranda
    Yang, Yachao
    Kim, Joseph
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    Yuling Xiao
    Jiang Chen
    Hui Zhou
    Xiaodong Zeng
    Zhiping Ruan
    Zhangya Pu
    Xingya Jiang
    Aya Matsui
    Lingling Zhu
    Zohreh Amoozgar
    Dean Shuailin Chen
    Xiangfei Han
    Dan G. Duda
    Jinjun Shi
    Nature Communications, 13
  • [43] Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    Xiao, Yuling
    Chen, Jiang
    Zhou, Hui
    Zeng, Xiaodong
    Ruan, Zhiping
    Pu, Zhangya
    Jiang, Xingya
    Matsui, Aya
    Zhu, Lingling
    Amoozgar, Zohreh
    Chen, Dean Shuailin
    Han, Xiangfei
    Duda, Dan G.
    Shi, Jinjun
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [44] Targeting DKK1 to Remodel the Tumor Microenvironment and Enhance Immune Checkpoint Blockade Therapy
    Shi, Tao
    Wei, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (03)
  • [45] Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
    Pingili, Ajeeth K.
    Chaib, Mehdi
    Sipe, Laura M.
    Miller, Emily J.
    Teng, Bin
    Sharma, Rahul
    Yarbro, Johnathan R.
    Asemota, Sarah
    Al Abdallah, Qusai
    Mims, Tahliyah S.
    Marion, Tony N.
    Daria, Deidre
    Sekhri, Radhika
    Hamilton, Alina M.
    Troester, Melissa A.
    Jo, Heejoon
    Choi, Hyo Young
    Hayes, D. Neil
    Cook, Katherine L.
    Narayanan, Ramesh
    Pierre, Joseph F.
    Makowski, Liza
    CELL REPORTS, 2021, 35 (12):
  • [46] Depletion of stromal cells remodels tumor microenvironment and potentiates immune checkpoint blockade in pancreatic cancer
    Rupert, Joseph
    Daquinag, Alexes
    Cai, Lingyi
    Dai, Yulin
    Zhao, Zhongming
    Anastassiou, Dimitris
    Kolonin, Mikhail
    CANCER RESEARCH, 2024, 84 (06)
  • [47] The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
    Luo, Hong
    Wang, Wenxiang
    Mai, Jia
    Yin, Rutie
    Cai, Xuyu
    Li, Qintong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Blockade of the fibroblast growth factor receptor (FGFR) system by the novel FGFR inhibitor BGJ398 modulates oncogenic signaling in human gastric cancer cells, endothelial cells and pericytes
    Moser, Christian
    Hackl, Christina
    Schlitt, Hans J.
    Geissler, Edward K.
    Lang, Sven A.
    CANCER RESEARCH, 2012, 72
  • [49] Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
    Chen, Xingyu
    Chen, Haotian
    He, Dong
    Cheng, Yaxin
    Zhu, Yuxing
    Xiao, Mengqing
    Lan, Hua
    Wang, Zhanwang
    Cao, Ke
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] Identification of a novel extracellular inhibitor of FGF2/FGFR signaling axis by combined virtual screening and NMR spectroscopy approach
    Pagano, Katiuscia
    Listro, Roberta
    Linciano, Pasquale
    Rossi, Daniela
    Longhi, Elisa
    Taraboletti, Giulia
    Molinari, Henriette
    Collina, Simona
    Ragona, Laura
    BIOORGANIC CHEMISTRY, 2023, 136